COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.
Identifieur interne : 000B90 ( Main/Exploration ); précédent : 000B89; suivant : 000B91COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.
Auteurs : Osnat C. Melamed [Canada] ; Tanya S. Hauck [Canada] ; Leslie Buckley [Canada] ; Peter Selby [Canada] ; Benoit H. Mulsant [Canada]Source :
- Substance abuse [ 1547-0164 ] ; 2020.
Abstract
The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.
DOI: 10.1080/08897077.2020.1784363
PubMed: 32697172
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.</title><author><name sortKey="Melamed, Osnat C" sort="Melamed, Osnat C" uniqKey="Melamed O" first="Osnat C" last="Melamed">Osnat C. Melamed</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hauck, Tanya S" sort="Hauck, Tanya S" uniqKey="Hauck T" first="Tanya S" last="Hauck">Tanya S. Hauck</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Buckley, Leslie" sort="Buckley, Leslie" uniqKey="Buckley L" first="Leslie" last="Buckley">Leslie Buckley</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mulsant, Benoit H" sort="Mulsant, Benoit H" uniqKey="Mulsant B" first="Benoit H" last="Mulsant">Benoit H. Mulsant</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32697172</idno><idno type="pmid">32697172</idno><idno type="doi">10.1080/08897077.2020.1784363</idno><idno type="wicri:Area/Main/Corpus">000044</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000044</idno><idno type="wicri:Area/Main/Curation">000044</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000044</idno><idno type="wicri:Area/Main/Exploration">000044</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.</title><author><name sortKey="Melamed, Osnat C" sort="Melamed, Osnat C" uniqKey="Melamed O" first="Osnat C" last="Melamed">Osnat C. Melamed</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hauck, Tanya S" sort="Hauck, Tanya S" uniqKey="Hauck T" first="Tanya S" last="Hauck">Tanya S. Hauck</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Buckley, Leslie" sort="Buckley, Leslie" uniqKey="Buckley L" first="Leslie" last="Buckley">Leslie Buckley</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mulsant, Benoit H" sort="Mulsant, Benoit H" uniqKey="Mulsant B" first="Benoit H" last="Mulsant">Benoit H. Mulsant</name><affiliation wicri:level="1"><nlm:affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><series><title level="j">Substance abuse</title><idno type="eISSN">1547-0164</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">32697172</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1547-0164</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Substance abuse</Title><ISOAbbreviation>Subst Abus</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.</ArticleTitle><Pagination><MedlinePgn>286-291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08897077.2020.1784363</ELocationID><Abstract><AbstractText>The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Osnat C</ForeName><Initials>OC</Initials><Identifier Source="ORCID">0000-0002-9663-2226</Identifier><AffiliationInfo><Affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauck</LastName><ForeName>Tanya S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buckley</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selby</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5401-2996</Identifier><AffiliationInfo><Affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulsant</LastName><ForeName>Benoit H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Addictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Subst Abus</MedlineTA><NlmUniqueID>8808537</NlmUniqueID><ISSNLinking>0889-7077</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">addiction</Keyword><Keyword MajorTopicYN="Y">alcohol</Keyword><Keyword MajorTopicYN="Y">cannabis</Keyword><Keyword MajorTopicYN="Y">clinical care</Keyword><Keyword MajorTopicYN="Y">clinical research</Keyword><Keyword MajorTopicYN="Y">cocaine</Keyword><Keyword MajorTopicYN="Y">opioids</Keyword><Keyword MajorTopicYN="Y">pandemic</Keyword><Keyword MajorTopicYN="Y">substance use disorders</Keyword><Keyword MajorTopicYN="Y">tobacco</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32697172</ArticleId><ArticleId IdType="doi">10.1080/08897077.2020.1784363</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Melamed, Osnat C" sort="Melamed, Osnat C" uniqKey="Melamed O" first="Osnat C" last="Melamed">Osnat C. Melamed</name></noRegion><name sortKey="Buckley, Leslie" sort="Buckley, Leslie" uniqKey="Buckley L" first="Leslie" last="Buckley">Leslie Buckley</name><name sortKey="Buckley, Leslie" sort="Buckley, Leslie" uniqKey="Buckley L" first="Leslie" last="Buckley">Leslie Buckley</name><name sortKey="Hauck, Tanya S" sort="Hauck, Tanya S" uniqKey="Hauck T" first="Tanya S" last="Hauck">Tanya S. Hauck</name><name sortKey="Hauck, Tanya S" sort="Hauck, Tanya S" uniqKey="Hauck T" first="Tanya S" last="Hauck">Tanya S. Hauck</name><name sortKey="Melamed, Osnat C" sort="Melamed, Osnat C" uniqKey="Melamed O" first="Osnat C" last="Melamed">Osnat C. Melamed</name><name sortKey="Mulsant, Benoit H" sort="Mulsant, Benoit H" uniqKey="Mulsant B" first="Benoit H" last="Mulsant">Benoit H. Mulsant</name><name sortKey="Mulsant, Benoit H" sort="Mulsant, Benoit H" uniqKey="Mulsant B" first="Benoit H" last="Mulsant">Benoit H. Mulsant</name><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name><name sortKey="Selby, Peter" sort="Selby, Peter" uniqKey="Selby P" first="Peter" last="Selby">Peter Selby</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32697172
|texte= COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32697172" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |